The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Recursion Pharmaceuticals Inc’s current trading price is -47.32% away from its 52-week high, while its distance from the 52-week low is 94.32%. The stock’s price range for this period has been between $4.54 and $16.75 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 4.01 million for the day, a number notably lower than the average daily volume of 7.17 million over the last three months.
Recursion Pharmaceuticals Inc experienced a somewhat steady performance in the stock market. The company’s stock reached a 1-year high of $16.75 on 07/19/23, while the lowest price for the same period was registered at $4.54 on 05/02/23.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Recursion Pharmaceuticals Inc (RXRX) has experienced a quarterly decline of -10.53% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.90B.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 9.86, with a change in price of +3.32. Similarly, Recursion Pharmaceuticals Inc recorded 6,352,024 in trading volume during the last 100 days, posting a change of +59.95%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for RXRX stands at 0.11. Similarly, the long-term debt-to-equity ratio is also 0.10.
RXRX Stock Stochastic Average
Recursion Pharmaceuticals Inc’s raw stochastic average for the past 50 days is presently 2.48%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 4.59%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 2.17% and 1.48%, respectively.
RXRX Stock Price Performance Analysis
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The index has shown a price loss of -10.53% this year. Over the last six months, there has been a weaker performance of 15.32%. The price of RXRX leaped by -31.13% during the last 30 days period. For the last 5-days stocks have slided -16.22%.
